Delivery Order SPE2DB22D3016-SPE2DB25FAEQ3

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Remifentanil 2 mg vials. The $1,836.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $10,242.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Remifentanil 5 mg vials, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $3,629.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REMIFENTANIL 1 MG VIALS, a critical pharmaceutical product, with a completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $3,640.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 2 mg vials, a specialized medication. This award is a delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This federal contract award is for the delivery of 2 mg vials of the opioid medication remifentanil, valued at $1,156.65. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,373.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4563335062 - REMIFENTANIL 2 MG VIALS, a critical pharmaceutical product used in various...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,511.20 firm fixed-price delivery order is for the supply of remifentanil, a specialty medication, to support military healthcare programs. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,633.40 firm fixed price delivery order is for the supply of Remifentanil 2 mg vials, a specialty medication used for pain management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,755.60 firm fixed price delivery order is for the supply of 1 mg vials of the drug remifentanil. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAEQ3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Remifentanil 2 mg vials. The $2,299.97 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/25/25, 10:19 AM